肠道菌群与肠道单一优势定植预测异基因造血细胞移植后菌血症
该研究对277例异基因造血细胞移植受者每周采集粪便行16S rRNA基因测序,分析肠道菌群优势定植与菌血症的关系。95例发生菌血症共130次事件,肠道优势定植对菌血症的阳性预测值低;凝固酶阴性葡萄球菌在肠道相对丰度>30%时与相应血流感染风险增加相关(PPV 38%)。
要点
- 肠道单一优势定植对菌血症的阳性预测值普遍较低,不宜单独作为预测工具。
- 凝固酶阴性葡萄球菌肠道丰度>30%与相应血流感染风险增加相关,PPV 38%。
- 移植后肠道菌群显著紊乱,尤其在随后发生菌血症的患者中。
核心结论
- 肠道优势定植与菌血症相关但预测价值不高,阳性预测值低。
- 凝固酶阴性葡萄球菌肠道相对丰度>30%与相应血流感染风险增加相关,PPV为38%。
- 肠道可能是异基因造血细胞移植后葡萄球菌入血的一个未被充分认识的门户。
研究设计与样本
- 对277例异基因造血细胞移植受者每周采集粪便,用16S rRNA基因PCR测序分析菌群组成并记录优势定植事件。
- 通过病历回顾捕获菌血症事件,计算粪便中检出该菌及10%、30%、50%丰度优势定植对菌血症的阳性预测值。
主要发现
- 277例受者中95例发生菌血症,共130次菌血症事件。
- 肠道优势定植与菌血症相关但阳性预测值低,预测力不强。
- 粪便中凝固酶阴性葡萄球菌相对丰度>30%与凝固酶阴性葡萄球菌血流感染风险增加相关,PPV为38%。
关键数值与推荐
- 粪便中凝固酶阴性葡萄球菌相对丰度>30%时,对相应血流感染的阳性预测值为38%。
- 分析的优势定植阈值包括10%、30%和50%相对丰度。
临床怎么用
- 不宜仅凭肠道单一优势定植预测菌血症,需结合临床综合判断。
- 对肠道凝固酶阴性葡萄球菌相对丰度>30%的移植受者,可提高对相应血流感染的警惕。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bacteremia is a frequent complication in patients undergoing allogeneic hematopoietic cell transplantation (HCT). Alterations to the gut microbiota after HCT have been associated with adverse outcomes including bacteremia and reduced overall survival. Previous studies suggest that loss of gut bacterial diversity and domination by a single species may predict bloodstream infections, but the degree of domination leading to the optimal positive predictive value (PPV) has not been defined. METHODS: Stool samples were collected weekly from allogeneic HCT recipients and were analyzed by 16S rRNA gene PCR with sequencing to determine gut microbiota composition and document domination events. Bacteremia events were captured by review of medical records. The PPV for bacteremia of any detection of that species in stool and for domination events at 10%, 30%, and 50% abundance were calculated. RESULTS: Of 277 HCT recipients, 95 experienced bacteremia, with 130 bacteremia events. Intestinal domination was associated with but not highly predictive for bacteremia, reflected by low PPV. Presence of coagulase-negative Staphylococcus in the gut at >30% relative abundance was associated with increased risk of coagulase-negative Staphylococcus bloodstream infections with PPV of 38%. CONCLUSIONS: Hematopoietic cell transplantation is associated with significant disruption to the gut microbiota, particularly in patients who subsequently develop bacteremia. Intestinal domination may not be as useful as previously thought given its low PPV for most species implicated in bloodstream infections. The association between gut colonization with Staphylococcus and bacteremia events suggests that the gut may be an under-recognized portal of entry for these organisms in patients after HCT.
引用
- DeMeules MM, Proll SC, Hua X, et al. Gut Microbiota and Intestinal Monodomination as a Predictor for Bacteremia in Allogeneic Hematopoietic Cell Transplant Recipients. J Infect Dis. 2026. PMID: 41733389. doi:10.1093/infdis/jiag005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。